
Umb Gene Research & Pharma Private Limited
About Umb Gene Research & Pharma Private Limited
Data last updated:
Umb Gene Research & Pharma Private Limited is a private limited company based in Rohtak, Haryana, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 12 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100HR2020PTC090031. Its GSTIN is 06AACCU6930G1ZD (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hita Sharma and Sidharath Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 1701 Ward No. 5 Pech Kapur Chand Railway Road, Rohtak, Haryana, India – 124001.
As per the financials filed for FY 2025, the company reported a revenue of ₹62.45 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹3.6 Lakh (net margin -5.8%) and EBITDA of ₹1.3 Lakh (EBITDA margin 2.1%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years.
As per MCA filings, the company has open charges of ₹26.5 Lakh on record.
Company details
Contact details
Umb Gene Research & Pharma Private Limited's registered office is in Rohtak, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressH No. 1701 Ward No. 5 Pech Kapur Chand Railway Road, Rohtak, Haryana, India – 124001
- IndustryResearch & Development, Science Research
To see the full contact details of Umb Gene Research & Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Umb Gene Research & Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Umb Gene Research & Pharma Private Limited, buy the company report.
Financials of Umb Gene Research & Pharma Private Limited
FY 2025 filings availableUmb Gene Research & Pharma Private Limited reported revenue of ₹62.45 Lakh (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 39% over three years, including a 13% fall in the latest year. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | -5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Umb Gene Research & Pharma Private Limited, buy the company report.
Board of directors of Umb Gene Research & Pharma Private Limited
Umb Gene Research & Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hita Sharma | Director | 12 Oct 2020 | 6 Years 1 Months | Current |
| Sidharath Kumar | Director | 12 Oct 2020 | 6 Years 1 Months | Current |
Peer comparison
Umb Gene Research & Pharma Private Limited is compared with the 4 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gradutech Services Private Limited | ₹65.26 Lakh (FY 2023) | 237.0% | Burari Village, Delhi, India | |||
| Umb Gene Research & Pharma Private Limitedthis company | ₹62.45 Lakh (FY 2025) | -₹3.6 Lakh | -5.8% | -13.0% | Rohtak, Haryana, India | |
| Tara Lifescience Private Limited | ₹62.02 Lakh (FY 2025) | 34.0% | Nagpur, Maharashtra, India | |||
| Natureanalytica Envirocare Solutions Private Limited | ₹62 Lakh (FY 2024) | 179.0% | Lucknow, Uttar Pradesh, India | |||
| Icomply Lifescience Solutions Private Limited | ₹61.95 Lakh (FY 2024) | 99.0% | Chengalpattu, Tamil Nadu, India |
To see the full peer comparison of Umb Gene Research & Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Mar 2025 | 101067712 | Canara Bank | ₹26.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Umb Gene Research & Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Umb Gene Research & Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Umb Gene Research & Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCU6930G1ZD | Haryana | Active | 10 Dec 2020 |
To see the full GST registrations and return filing status of Umb Gene Research & Pharma Private Limited, buy the company report.
Recent activity
Umb Gene Research & Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Hita Sharma was appointed as Director on 12 Oct 2020.
Frequently asked questions
Umb Gene Research & Pharma is an active private limited company based in Rohtak, Haryana, India. The company works in science research, within the research and development industry. It was incorporated on 12 October 2020 (6+ years old) and is registered under CIN U73100HR2020PTC090031.
Umb Gene Research & Pharma has 2 current directors:
- Hita Sharma - Director
- Sidharath Kumar - Director
The latest financial statements of Umb Gene Research & Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Umb Gene Research & Pharma is 06AACCU6930G1ZD, registered in Haryana.
The CIN (Corporate Identification Number) of Umb Gene Research & Pharma is U73100HR2020PTC090031. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Umb Gene Research & Pharma was incorporated on 12 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Umb Gene Research & Pharma by revenue are Gradutech Services Private Limited, Tara Lifescience Private Limited, Natureanalytica Envirocare Solutions Private Limited, Icomply Lifescience Solutions Private Limited, all in the same principal business activity (scientific research and development).
Hita Sharma was appointed as Director on 12 Oct 2020. Sidharath Kumar was appointed as Director on 12 Oct 2020.
The registered office of Umb Gene Research & Pharma is at H No. 1701 Ward No. 5 Pech Kapur Chand Railway Road, Rohtak, Haryana, India – 124001.
Umb Gene Research & Pharma operates in the research and development industry, in the science research segment.
Umb Gene Research & Pharma has open charges of ₹26.5 Lakh and no satisfied charges on record as per latest MCA filings.

